Optimization, ex-vivo penetration and in-vivo evaluation of PEGylated nanostructured lipid carriers of olmesartan medoxomil to enhance transdermal delivery

rofida albash, Aly A. Abdelbary, Hanan refai, mohamed nabarawi

Open source

DOI
10.34172/apb.46458
Published
2026-05-19
Container
Advanced Pharmaceutical Bulletin
Publisher
Maad Rayan Publishing Company
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.34172/apb.46458,
  title = {Optimization, ex-vivo penetration and in-vivo evaluation of PEGylated nanostructured lipid carriers of olmesartan medoxomil to enhance transdermal delivery},
  author = {rofida albash and Aly A. Abdelbary and Hanan refai and mohamed nabarawi},
  year = {2026},
  journal = {Advanced Pharmaceutical Bulletin},
  doi = {10.34172/apb.46458},
  url = {https://doi.org/10.34172/apb.46458}
}

RIS

TY  - JOUR
TI  - Optimization, ex-vivo penetration and in-vivo evaluation of PEGylated nanostructured lipid carriers of olmesartan medoxomil to enhance transdermal delivery
AU  - rofida albash
AU  - Aly A. Abdelbary
AU  - Hanan refai
AU  - mohamed nabarawi
PY  - 2026
JO  - Advanced Pharmaceutical Bulletin
DO  - 10.34172/apb.46458
UR  - https://doi.org/10.34172/apb.46458
ER  - 

APA

albash, R., Abdelbary, A. A., refai, H., & nabarawi, M. (2026). Optimization, ex-vivo penetration and in-vivo evaluation of PEGylated nanostructured lipid carriers of olmesartan medoxomil to enhance transdermal delivery. Advanced Pharmaceutical Bulletin. https://doi.org/10.34172/apb.46458

Source records